Salesforce Stock Surges, but 96% of Its EPS Surprise Came From Investments
ภาษาไทย Español Português 한국어 简体中文 繁體中文 日本語 Tiếng Việt Bahasa Indonesia Монгол ئۇيغۇر تىلى العربية Русский हिन्दी

Salesforce Stock Surges, but 96% of Its EPS Surprise Came From Investments

Author: Benny Lam

Published on: 2026-08-27   
Updated on: 2026-08-27

CRM
Buy: -- Sell: --
Trade Now

Salesforce stock surged in extended trading after Q2 earnings, yet the headline profit beat was far less extraordinary than it appeared. Of the $2.63 gap between Salesforce’s $5.90 adjusted EPS and the $3.27 consensus, $2.53 came from strategic-investment gains, leaving underlying EPS near $3.37.


The stronger signal came from 14% constant-currency cRPO growth and the fastest new-order growth in four years, evidence that AI adoption is supporting customer commitments rather than visibly eroding them.

Salesforce Stock

Salesforce Stock Key Takeaways

  • The apparent 80% EPS beat shrinks to roughly 3% after removing strategic-investment gains, separating the headline profit surprise from Salesforce’s operating performance.

  • cRPO accelerated to 14% in constant currency and new-order growth reached a four-year high, giving the rally a stronger fundamental explanation.

  • Anthropic connects Salesforce’s investment gain with a broader AI strategy, although Salesforce does not disclose Anthropic’s exact share of the portfolio gain.

  • Q3 cRPO near 14% is the next clean test, particularly as acquisitions continue to lift reported revenue growth.


Salesforce’s 80% EPS Beat Shrinks to About 3% Without Investment Gains

Salesforce reported $5.90 in adjusted EPS against a $3.27 consensus, yet strategic-investment gains contributed $2.53 per share. Excluding that contribution leaves adjusted EPS near $3.37, turning an apparent 80% surprise into an underlying beat of roughly 3%.


Revenue showed the same lack of a blowout. Salesforce generated $11.35 billion against approximately $11.33 billion expected.

Metric Reported Underlying
Adjusted EPS $5.90 ~$3.37 ex-investments
EPS vs consensus +80% ~+3%
Revenue $11.35B ~0.2% beat


Stronger Contracted Demand Best Explains Salesforce’s Rally

Current remaining performance obligation, or cRPO, reached $33.5 billion and grew 14% in constant currency, up from 13% in Q1, while net-new annual order value recorded its fastest growth in four years.


Slack posted its strongest quarterly new-order growth since the acquisition, while premium Agentforce bookings more than doubled from Q1. The gains extended across several parts of the business rather than relying on one standout metric.


Rising AI adoption alongside stronger contracted demand weakens the thesis that generative AI is already cannibalising Salesforce’s software economics. The quarter offered evidence that new AI products can expand usage while the underlying customer relationship remains anchored to Salesforce.


Salesforce’s Rally Reflects a Reset in AI Risk, Not a Blowout Quarter

CRM entered earnings roughly 22% lower for the year, while options markets had implied an earnings move of only about 7%. The eventual 13–14% after-hours jump ran well beyond the move priced before the report.


That reaction was much larger than the change in Salesforce’s near-term financial outlook. The company raised its FY27 revenue midpoint by $200 million, and only $100 million of that increase came from stronger organic growth.


A double-digit share-price move alongside a modest organic forecast increase points to a change in the risk discount attached to Salesforce rather than an equivalent improvement in near-term earnings power. The report challenged one of the assumptions that had weighed on CRM throughout the year, that generative AI would rapidly weaken the economics of established enterprise software.


Salesforce did not need a dramatic revenue forecast increase to trigger a large move. It needed credible evidence that the market had become too pessimistic about what AI meant for the durability of its core business.


Anthropic Shows How Salesforce Can Benefit as AI Changes the Interface

Anthropic affects Salesforce through two separate relationships. Salesforce owns an investment stake in the AI company, first backed through Salesforce Ventures in 2023, while Claudeforce brings Salesforce data and workflows directly into Claude. Anthropic reached a $965 billion post-money valuation in May 2026, increasing the value of stakes accumulated in earlier funding rounds.


Salesforce does not disclose how much of its $2.613 billion quarterly strategic-investment gain came from Anthropic. Attributing the entire gain to one holding would go beyond what the company has reported.


The first Claudeforce integration includes 37 prebuilt sales skills that let Claude work with customer records, pipeline information and business processes inside Salesforce. Open beta is planned for September 2026.


Agentforce adds evidence that Salesforce is monetising the AI shift rather than merely defending against it. ARR exceeded $1.5 billion and grew more than 240% year over year, while premium Agentforce bookings more than doubled from Q1. Salesforce broadened the ARR definition in Q2 to include Slackbot and Headless 360, so the headline growth rate is not perfectly comparable with earlier periods.


Claude can replace parts of the traditional software interface without replacing the customer records, permissions and workflows beneath it. If enterprise users increasingly reach business data through conversational agents, Salesforce can still retain the system underneath the interaction even when another company’s AI becomes the front door.


Q3 cRPO Will Test Whether Salesforce’s Demand Acceleration Lasts

Informatica is expected to contribute slightly more than four percentage points to Q3 revenue growth, making headline revenue a less clean measure of underlying demand.


Salesforce expects cRPO to grow about 14% in constant currency in Q3, excluding pending contributions from Contentful and Fin. Matching that pace would show that stronger customer commitments are carrying beyond one quarter.


A clear slowdown would revive doubts that AI adoption is translating into durable contracted growth. Holding near the current rate would make the Q2 improvement harder to dismiss as a temporary rebound from depressed expectations.


Salesforce Stock FAQ

How much of Salesforce’s investment gain came from Anthropic?

Salesforce has not disclosed Anthropic’s exact contribution. The company reported $2.613 billion in total strategic-investment gains across several holdings, so assigning the full amount to Anthropic would go beyond what Salesforce has reported.


Is Agentforce’s 240% ARR growth directly comparable with last year?

Not perfectly. Salesforce expanded the Agentforce ARR definition in Q2 to include Slackbot and Headless 360. The figure still shows rapid expansion, but the revised definition prevents a completely like-for-like comparison with earlier periods.


How much is Informatica adding to Salesforce’s growth?

Informatica contributed $456 million to Q2 revenue and is expected to add slightly more than four percentage points to Q3 revenue growth. That acquisition contribution makes reported revenue growth less useful on its own when judging underlying demand.


Will Salesforce’s $5.90 EPS repeat next quarter?

Another investment-driven gain of the same size is not guaranteed. Salesforce says future gains and losses from its strategic-investment portfolio cannot be forecast, while its outlook assumes no future change in those investment values. Operating demand will therefore carry more weight in the next earnings comparison.


Salesforce’s Rally Now Needs Operating Proof

The next earnings report will determine whether this quarter marked a durable change in Salesforce’s growth profile or simply reset expectations after a difficult year. Salesforce does not need another $5.90 EPS print. It needs contracted demand to prove the surge was in the business, not the accounting.

Disclaimer: This material is for general information purposes only and is not intended as (and should not be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by EBC or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.